NCT05164146View on ClinicalTrials.gov

The Comparison of Hypotension Incidence Between Remimazolam and Propofol in Hypertensive Patients Undergoing Neurosurgery

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 23, 2022

Primary Completion Date

August 10, 2022

Study Completion Date

August 10, 2022

Conditions
Patients Undergoing Neurosurgery
Interventions
DRUG

propofol

during the induction, remimazolam dose was controlled according to sedline (Psi target 40)

DRUG

remimazolam

During induction, remimazolam dose was controlled according to sedline (Psi target 40)

Trial Locations (1)

Unknown

Yonsei University Health System, Severance Hospital, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER